Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |